To study the effect of gemcabene on CRP promoter activity, wild-type and mutated promoter constructs were transfected into the Alexander human hepatoma cells followed by treatments as shown in Fig. 4B–D. This evidence concerns the gene CRP and hepatocellular carcinoma.